IP Library Granted Patent US 10,822,638
Granted Patent B2
US 10,822,638 · App. 15/335,111 · Granted Nov 3, 2020

Isolation and detection of DNA from plasma

Inventors: Hatim Allawi (Middleton, WI); Graham P. Lidgard (Middleton, WI); Brian Aizenstein (Madison, WI); Tamara J. Sander (Mazomanie, WI); Maria Giakoumopoulos (Middleton, WI); Michael W. Kaiser (Stoughton, WI); Melissa M. Gray (Madison, WI); Abram Michael Vaccaro (Rio, WI)
Assignee: Exact Sciences Development Company, LLC
C12Q1/6806C12N15/1006C12Q1/686C12Q1/6837C12Q2600/154C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,822,638
App. No.
15/335,111
Granted
Nov 3, 2020
Kind
B2
Abstract

Provided herein is technology relating to the amplification-based detection of bisulfite-treated DNAs and particularly, but not exclusively, to methods and compositions for multiplex amplification of low-level sample DNA prior to further characterization of the sample DNA. The technology further provides methods for isolating DNA from blood or blood product samples, e.g., plasma samples.

Claims (37)

1. A method of processing a plasma sample, the method comprising:

a) combining a plasma sample with

i) protease;

ii) a first lysis reagent, said first lysis reagent comprising

guanidine thiocyanate,

non-ionic detergent;

to form a mixture wherein proteins are digested by said protease;

b) to the mixture of step a) adding

iii) silica particles,

iv) a second lysis reagent, said second lysis reagent comprising:

guanidine thiocyanate;

non-ionic detergent;

and

v) isopropyl alcohol,

under conditions wherein DNA is bound to said silica particles;

c) separating silica particles with bound DNA from the mixture of b);

d) to the separated silica particles with bound DNA from step c) adding a first wash solution, said first wash solution comprising guanidine hydrochloride or guanidine thiocyanate and ethyl alcohol;

e) separating the silica particles with bound DNA from said first wash solution;

f) to the separated silica particles with bound DNA from step e) adding a second wash solution, said second wash solution comprising a buffer and ethyl alcohol;

g) separating the washed silica particles with bound DNA from said second wash solution;

h) eluting DNA from said washed silica particles with bound DNA from step g) to produce an isolated DNA sample.

2. The method of claim 1 , wherein steps f)-g) are repeated 1 to 3 additional times prior to step h).

3. The method of claim 1 , wherein the non-ionic detergents in the first lysis reagent and the second lysis reagent are the same or different, and are selected from the group consisting of polyethylene glycol sorbitan monolaurate (Tween-20), octylphenoxypolyethoxyethanol (Nonidet P-40), and octylphenoxy poly(ethyleneoxy) ethanol, branched (IGEPAL CA-630).

4. The method of claim 1 , wherein said protease is Proteinase K protease.

5. The method of claim 1 , further comprising a step after step g) and prior to step h) of drying the washed silica particles with bound DNA.

6. The method of claim 1 , wherein the mixture of step a) further comprises a DNA process control.

7. The method of claim 6 , wherein said DNA process control comprises a zebrafish Ras association domain (RalGDS/AF-6) family 1 (RASSF1) sequence.

8. The method of claim 7 , wherein said DNA process control comprising a zebrafish RASSF1 sequence is synthetic DNA.

9. The method of claim 1 , wherein the mixture of step a) further comprises bulk fish DNA.

10. The method of claim 1 , wherein said plasma sample has a volume of at least 2 mL.

11. The method of claim 1 , wherein said first lysis reagent comprises about 4.3 M guanidine thiocyanate and 10% w:v IGEPAL CA-630 and/or wherein said second lysis reagent comprises 4.3 M guanidine thiocyanate and 10% w:v IGEPAL CA-630 and is combined with the isopropyl alcohol prior to step b).

12. The method of claim 1 , wherein said first wash solution comprises about 3 M guanidine hydrochloride or 3 M guanidine thiocyanate and about 57% ethyl alcohol and/or said second wash solution comprises about 80% ethyl alcohol and about 20% 10 mM Tris pH 8.0 buffer.

13. The method of claim 1 , further comprising analyzing said isolated DNA sample for multiple target nucleic acids, comprising:

a) treating said isolated DNA sample with bisulfite to produce a bisulfite treated DNA sample;

b) treating said bisulfite-treated DNA sample to an amplification reaction under conditions wherein at least five different target regions, if present in said sample, are amplified to form a pre-amplified mixture;

c) partitioning said pre-amplified mixture into a plurality of different detection assay reaction mixtures; and

d) conducting a plurality of detection assays with said detection assay reaction mixtures, wherein said at least five different target regions, if present in said sample at step a), are detected in one or more of said plurality of different detection assay reaction mixtures.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 044119/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: ALLAWI, HATIM T.; LIDGARD, GRAHAM P.; AIZENSTEIN, BRIAN; SANDER, TAMARA J.; GIAKOUMOPOULOS, MARIA; KAISER, MICHAEL W.; GRAY, MELISSA M.; VACCARO, ABRAM MICHAEL
To: EXACT SCIENCES CORPORATION
Reel/Frame 040872/0369 →
Continuity (2)
Provisional Application 62249097 · Oct 30, 2015
Related Publication 20170121704A1 · May 4, 2017
Cited By (8)
US 12,188,093 US 12,297,510 US 12,319,969 US 12,391,978 US 12,571,025 US 12,601,011 US 12,606,873 US 12,612,664